Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-06-06
2006-06-06
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S192100, C530S350000, C530S387300
Reexamination Certificate
active
07056516
ABSTRACT:
The present invention relates to a novel I-FLICE-1 or I-FLICE-2 protein which is a novel inhibitor of TNFR-1 and CD-95 induced apoptosis. In particular, isolated nucleic acid molecules are provided encoding the human I-FLICE-1 or I-FLICE-2 protein. I-FLICE-1 or I-FLICE-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of I-FLICE-1 or I-FLICE-2 activity. Also provided are therapeutic methods for treating diseases and disorders associated with apoptosis.
REFERENCES:
patent: 2285669 (1998-10-01), None
patent: 0 816 499 (1998-01-01), None
patent: 0 841 399 (1998-05-01), None
patent: WO 94/04686 (1994-03-01), None
patent: WO 96/05306 (1996-02-01), None
patent: WO 97/32996 (1997-09-01), None
patent: WO 98/33883 (1998-08-01), None
patent: WO 98/44104 (1998-10-01), None
patent: WO 98/52963 (1998-11-01), None
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz, et al., (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Mikayama et al, Molecular cloning and functional expression of a cDNA encoding gycosylation-inhibiting factor, Nov. 1993, Proc. Natl. Acad. Sci, USA vol. 90: 10056-10060.
Skolnick et al., From genes to protein structure and function: novel applications of computational approaches in the genomic era, Jan. 2000, Trends in Biotech. 18(1): 34-39.
Attwood et al., The babel of bioinformatics, Oct. 2000, Science 290 (5491): 471-473.
U.S. Appl. No. 09/912,293, filed Jul. 26, 2001, Rosen et al., pp. 1-75 (pp. 1 & 2 partially redacted); portion of Table 2; and SEQ ID Nos.: 164706, 215903, and 219749.
Adams, M.D. et al., “Complementary DNA sequencing: expressed sequence tags and human genome project,”Science252:1651-1656 (1991).
Adams, M.D. et al., “Sequence identification of 2,375 human brain genes,”Nature355:632-634 (1992).
Adams, M.D. et al., “Rapid cDNA sequence (expressed sequence tags) from a directionally cloned human infant brain cDNA library,”Nature genetics4:373-380 (1993).
Adams, M.D. et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence,”Nature377:3-174 (1995).
Alnemri, E.S et al., “Human ICE/CED-3 protease nomenclature,”Cell87:171 (Oct. 1996).
Bertin, J. et al., “Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis,”Proc. Natl. Sci. Acad. USA94:1172-1176 (Feb. 1997).
Boldin, M.P. et al., “Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF Receptor-induced cell death,”Cell85:803-815 (Jun. 1996).
Chinnaiyan, A.M. et al., “FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis,”Cell81:505-512 (1995).
Chinnaiyan, A.M. et al., “FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor-receptor-induced apoptosis,”J. Biol. Chem. 271(9):4961-4965 (Mar. 1996).
Chinnaiyan, A.M. and V.M. Dixit, “The cell-death machine,”Curr. Biol.6:55-562 (May 1996).
Fernandes-Alnemri, T. et al., “In vitroactivation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains,”Proc. Natl. Acad. Sci. USA93:7464-7469 (Jul. 1996).
Fraser, A. and G. Evan, “A license to kill,”Cell85:781-784 (Jun. 1996).
Henkart, P.A., “ICE family proteases: mediators of all apoptotic cell death?,”Immunity4:195-201 (Mar. 1996).
Hu, S. et al., “A novel family of viral death effector domain-containing molecules that inhibit both CD-95 and tumor necrosis factor receptor-1-induced apoptosis,”J. Biol. Chem. 272(15):9621-9624 (Apr. 1997).
Hu, S. et al., “I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis,”J. Biol. Chem. 272(28):17255-17257 (Jul. 1997).
Irlmer, M. et al., “Inhibition of death receptor signals by cellular FLIP,”Nature388:190-195 (Jul. 1997).
Muzio, M. et al., “FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex,”Cell85:817-827 (Jun. 1996).
Muzio, M. et al., “FLICE induced apoptosis in a cell-free system,”J. Biol. Chem. 272(5):2952-2956 (Jan. 1997).
O'Rourke, K.M. et al., “Thrombospondin 1 and Thrombospondin 2 are expressed as both homo- and heterotrimers,”J. Biol. Chem. 267(35):24921-24924 (1992).
Rotonda, J. et al., “The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis,”Nature Structural Biology3(7):619-625 (Jul. 1996).
Shen, Y. and T.E. Shenk, “Viruses and apoptosis,” Curr. Biol. 5:105-111 (1995).
Shu, H.-B. et al., “Casper is a FADD- and caspase-related inducer of apoptosis,”Immunity6:751-763 (Jun. 1997).
Srinivasula, S.M. et al., “Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases,”Proc. Natl. Acad. Sci. USA93:14486-14491 (Dec. 1996).
Thome, M. et al., “Viral FLICE-inhibitory protein (FLIPs) prevent apoptosis induced by death receptors,”Nature386:517-521 (Apr. 1997).
Vincenz, C. and V.M. Dixit, “Fas-associated death domain protein interleukin 1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximately involved in CD95- and p55-mediated death signaling,”J. Biol. Chem. 272(10):6578-6583 (Mar. 1997).
Walker, N.P.C. et al., “Crystal structure of the cysteine protease interleukin 1β-converting enzyme: a (p20/p10)2homodimer,”Cell78:343-352 (1994).
Wilson, K.P. et al., “Structure and mechanism of interleukin 1β-converting enzyme,”Nature370:270-275 (1994).
NCBI Entrez, Genbank Report, Accession No. T05118, from Adams, M.D. et al. (1993), with revision history.
NCBI Entrez, Genbank Report, Accession No. Z42895, from Auffray, C. et al. (1994), with revision history.
NCBI Entrez, Genbank Report, Accession No. T48754, from Hillier, L. et al. (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. F13176, from Auffray, C. et al., (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. T93307, from Hillier, L. et al. (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. H15978, from Hillier, L. et al., (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. H15052, from Hillier, L. et al. (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. T30922, from Adams, M.D. et al. (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. T30864, from Adams, M.D. et al. (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. H68343, from Hillier, L. et al. (1995), with revision history.
NCBI Entrez, Genbank Report, Accession No. D83882, Takeda, J. (Apr. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. W52946, from Hillier, L. et al. (May 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. W60406, from Hillier, L. et al. (Jun. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. W23795, from Hillier, L. et al. (Aug. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. N94588, from Hillier, L. et al. (Aug. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. C05795, from Takeda J. (Oct. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. C05730, Takeda J. (Oct. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. AA135811, from Hillier, L. et al. (Nov. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. AA149562, from Hillier, L. et al. (Dec. 1996), with revision history.
NCBI Entrez, Genbank Report, Accession No. AA151642, f
Dixit Vishva M.
Gentz Reiner L.
Kenny Joseph J.
Ni Jian
Rosen Craig A.
Chan Christina
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Huynh Phuong
The Regents of the University
LandOfFree
I-FLICE, a novel inhibitor of tumor necrosis factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with I-FLICE, a novel inhibitor of tumor necrosis factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and I-FLICE, a novel inhibitor of tumor necrosis factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3679548